CLINICAL TRIAL: PHASE I TRIAL OF ABRAXANE IN COMBINATION WITH GEMCITABINE IN SOL

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是观察吉西他滨所能给予的最高剂量的亚伯拉沙。将对不同剂量的亚伯拉沙星进行测试。给予吉西他滨的剂量将是标准剂量--不同剂量的吉西他滨没有进行测试。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to see the highest amount of Abraxane that can be given with gemcitabine. Different doses of Abraxane will be tested. The amount of gemcitabine that is given will be the standard dose - different doses of gemcitabine are not being tested.